可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]LloydJones D,Adams R,Carnethon M,et al.Heart disease and stroke statistics--2009 update:a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee[J].Circulation,2009,119(3):480-486.
[2]Herman JG,Baylin SB.Gene silencing in cancer in association with promoter hypermethylation[J].N Eng J Med,2003,349(21):2042-2054.
[3]Turunen MP,Aavik E,Yl?-Herttuala S.Epigenetics and atherosclerosis[J].Biochim Biophys Acta,2009,1790(9):886-891.
[4]Movassagh M,Choy MK,Goddard M,et al.Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure[J].PLoS One,2010,5(1):e8564.
[5]Hang CT,Yang J,Han P,et al.Chromatin regulation by Brg1 underlies heart muscle development and disease[J].Nature,2010,466(7302):62-67.
[6]Hedrich CM,Tsokos GC. Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases[J].Trends Mol Med,2011,17(12):714-724.
[7]Symonds ME,Sebert SP,Hyatt MA,et al.Nutritional programming of the metabolic syndrome[J].Nat Rev Endocrinol,2009,5(11):604-610.
[8]Suzuki MM,Bird A.DNA methylation landscapes: provocative insights from epigenomics[J].Nat Rev Genet,2008,9(6):465-476.
[9]Law JA,Jacobsen SE.Establishing,maintaining and modifying DNA methylation patterns in plants and animals[J].Nat Rev Genet,2010,11(3):204-220.
[10]Hedrich CM,Bream JH.Cell type-specific regulation of IL-10 expression in inflammation and disease[J].Immunol Res,47(3):185-206.
[11]Kim M,Long TI,Arakawa K,et al.DNA methylation as a biomarker for cardiovascular disease risk[J].PLoS One,2010,5(3):e9692.
[12]Kim J,Kim JY,Song KS,et al.Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence[J].Biochim Biophys Acta,2007,1772(1):72-80.
[13]Zawadzki C,Chatelain N,Delestre M,et al.Tissue factor pathway inhibitor2 gene methylation is associated with low expression in carotid atherosclerotic plaques[J].Atherosclerosis,2009,204(2):e4-e14.
[14]智艳芳,黄彦生,李著华,等.动脉粥样硬化病人LDL受体基因启动子序列的高甲基化改变[J].分子细胞生物学报,2007,40(6):419-427.
[15]Kulkarni A,ChavanGautam P,Mehendale S,et al.Global DNA methylation patterns in placenta and its association with maternal hypertension in preeclampsia[J].DNA Cell Biol,2011,30(2):79-84.
[16]Smolarek I,Wyszko E,Barciszewska AM,et al.Global DNA methylation changes in blood of patients with essential hypertension[J].Med Sci Monit,2010,16(3):CR149-CR155.
[17]Bogdarina IG,King PJ,Clark AJ.Characterization of the angiotensin (AT1b) receptor promoter and its regulation by glucocorticoids[J].J Mol Endocrinol,2009,43(2):73-80.
[18]Friso S,Pizzolo F,Choi SW,et al.Epigenetic control of 11betahydroxysteroid dehydrogenase 2 gene promoter is related tohuman hypertension[J].Atherosclerosis,2008,199(2):323-327.
[19]Kao YH,Chen YC,Chen CC,et al.Tumor necrosis factoralphadecreases sarcoplasmic reticulum Ca2+ATPase expressions via thepromoter methylation in cardiomyocytes[J].Crit Care Med,2010,38(1):217-222.
[20]Haas J,Frese KS,Park YJ,et al.Alterations in cardiac DNA methylation in human dilated cardiomyopathy[J].EMBO Mol Med,2013,5(3):413-429.